These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12443626)

  • 1. Fondaparinux versus enoxaparin for prevention of venous thromboembolism.
    Borja J; Olivella P; Curto J
    Lancet; 2002 Nov; 360(9345):1603-4; author reply 1605. PubMed ID: 12443626
    [No Abstract]   [Full Text] [Related]  

  • 2. Fondaparinux versus enoxaparin for prevention of venous.
    Thaler H; Sim E
    Lancet; 2002 Nov; 360(9345):1604; author reply 1605. PubMed ID: 12443627
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of venous thromboembolism with fondaparinux.
    Marlovits S
    N Engl J Med; 2002 Mar; 346(12):940-2; author reply 940-2. PubMed ID: 11911133
    [No Abstract]   [Full Text] [Related]  

  • 4. Fondaparinux versus enoxaparin for prevention of venous.
    Morris E
    Lancet; 2002 Nov; 360(9345):1604-5; author reply 1605. PubMed ID: 12443628
    [No Abstract]   [Full Text] [Related]  

  • 5. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.
    Turpie AG; Bauer KA; Eriksson BI; Lassen MR;
    Lancet; 2002 May; 359(9319):1721-6. PubMed ID: 12049860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.
    Lassen MR; Bauer KA; Eriksson BI; Turpie AG;
    Lancet; 2002 May; 359(9319):1715-20. PubMed ID: 12049858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The cost-effectiveness of fondaparinux compared to enoxaparin as prophylaxis for deep-vein thrombosis in Denmark].
    Olsen J; Gundgaard J; Borris LC
    Ugeskr Laeger; 2005 May; 167(21):2273-9. PubMed ID: 15962854
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of venous thromboembolism with fondaparinux.
    Murashige N; Kami M
    N Engl J Med; 2002 Mar; 346(12):940-2; author reply 940-2. PubMed ID: 11907297
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost analysis: fondaparinux versus preoperative and postoperative enoxaparin as venous thromboembolic event prophylaxis in elective hip arthroplasty.
    Wade WE; Spruill WJ; Leslie RB
    Am J Orthop (Belle Mead NJ); 2003 Apr; 32(4):201-5. PubMed ID: 12723772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group.
    Comp PC; Spiro TE; Friedman RJ; Whitsett TL; Johnson GJ; Gardiner GA; Landon GC; Jové M;
    J Bone Joint Surg Am; 2001 Mar; 83(3):336-45. PubMed ID: 11263636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism prophylaxis: role of factor xa inhibition by fondaparinux.
    Turpie AG
    Surg Technol Int; 2004; 13():261-7. PubMed ID: 15744699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thromboprophylaxis in hip and knee arthroplasty. Are the new anticoagulants better than those previously used?].
    Nielsen JD
    Ugeskr Laeger; 2005 May; 167(21):2261-5. PubMed ID: 15962850
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of venous thromboembolism with fondaparinux.
    Priestley M
    N Engl J Med; 2002 Mar; 346(12):940-2; author reply 940-2. PubMed ID: 11911134
    [No Abstract]   [Full Text] [Related]  

  • 14. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.
    Eriksson BI; Bauer KA; Lassen MR; Turpie AG;
    N Engl J Med; 2001 Nov; 345(18):1298-304. PubMed ID: 11794148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of fondaparinux versus enoxaparin as venous thromboembolism prophylaxis in elective hip replacement surgery.
    Spruill WJ; Wade WE; Leslie RB
    Blood Coagul Fibrinolysis; 2004 Oct; 15(7):539-43. PubMed ID: 15389119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
    Bauer KA; Eriksson BI; Lassen MR; Turpie AG;
    N Engl J Med; 2001 Nov; 345(18):1305-10. PubMed ID: 11794149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombosis prophylaxis and rational pharmacotherapy].
    Munck LK; Andersen SE; Christensen HR
    Ugeskr Laeger; 2005 Aug; 167(33):3067-8; author reply 3068-70. PubMed ID: 16109260
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost consequence analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery in Belgium.
    Annemans L; Minjoulat-Rey MC; De Knock M; Vranckx K; Czarka M; Gabriel S; Haentjens P
    Acta Clin Belg; 2004; 59(6):346-57. PubMed ID: 15819379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fondaparinux and prolonged thromboprophylaxis after hip fracture surgery.
    Nurmohamed MT
    Arch Intern Med; 2003 Dec 8-22; 163(22):2789; author reply 2790. PubMed ID: 14662637
    [No Abstract]   [Full Text] [Related]  

  • 20. Fondaparinux versus enoxaparin for the prevention of venous thromboembolism.
    Doggrell SA
    Expert Opin Pharmacother; 2002 Apr; 3(4):455-7. PubMed ID: 11934350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.